RSS-Feed abonnieren
DOI: 10.1055/s-2006-944261
Selektive Serotoninwiederaufnahmehemmer (SSRI) in der Behandlung von Paraphilien
Eine retrospektive StudieSelective Serotonine Reuptake Inhibitors (SSRI) in the Treatment of ParaphiliaA Retrospective StudyPublikationsverlauf
Publikationsdatum:
10. Oktober 2006 (online)
![](https://www.thieme-connect.de/media/fdn/200706/lookinside/thumbnails/10.1055-s-2006-944261-1.jpg)
Zusammenfassung
Neben antihormonellen Substanzen werden seit ca. 15 Jahren auch Selektive Serotoninwiederaufnahmehemmer (SSRI) zur Behandlung von Paraphilien eingesetzt. In dieser ersten, im deutschsprachigen Raum durchgeführten, offenen, unkontrollierten Studie wurden 16 ambulant mit einem SSRI und psychotherapeutisch behandelte, paraphile Patienten retrospektiv zu Symptomveränderungen und zur Behandlungszufriedenheit befragt. Es zeigte sich ein deutlicher Rückgang der paraphilen Symptomatik bei insgesamt hoher Behandlungszufriedenheit, trotz relativ häufig berichteter unerwünschter Medikamentenwirkungen. Die medikamentöse Behandlung mit SSRI stellt eine wichtige Ergänzung in der Behandlung paraphiler Patienten, insbesondere mit sog. „Hands-off”-Delikten dar.
Abstract
For about 15 years selective serotonine reuptake inhibitors (SSRI) have been used in the treatment of paraphilias. In an open, uncontrolled, retrospective study, which was the first in the German speaking countries we investigated 16 male outpatients, who have been treated for different paraphilias with SSRI and psychotherapy. There was a marked reduction in paraphilic symptoms. Despite high rates of sexual side effects most patients reported a high overall treatment satisfaction. SSRI are an important addition in pharmacological treatment of paraphilic patients, especially with a risk of so called “hands-off” delinquency.
Schlüsselwörter
Paraphilien - Pädophilie - Sexualstraftäter - SSRI - Pharmakotherapie
Key words
paraphilias - pedophilia - sex offender - SSRI - pharmacotherapy
Literatur
- 1 Kafka M P, Hennen J. The paraphilia-related disorders: an empirical investigation of nonparaphilic hypersexuality disorders in outpatient males. J Sex Marital Ther. 1999; 25 305-319
- 2 Briken P, Berner W, Noldus J, Nika E, Michl U. Therapie mit dem LHRH-Agonisten Leuprorelinacetat bei Paraphilien und sexuell aggressiven Impulshandlungen. Nervenarzt. 2000; 71 380-385
- 3 Briken P, Nika E, Berner W. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists. J Sex Marital Ther. 2001; 27 45-55
- 4 Briken P, Hill A, Berner W. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review. J Clin Psychiat. 2003; 64 890-897
- 5 Bianchi M. Fluoxetine-treatment of exhibitionism (letter). Am J Psychiat. 1990; 147 1089-1090
- 6 Lorefice L S. Fluoxetine-treatment of a fetish (letter). J Clin Psychiat. 1991; 52 41
- 7 Perilstein R D, Lipper S, Friedmann L J. Three cases of paraphilia responsive to fluoxetine-treatment. J Clin Psychiat. 1991; 52 169-170
- 8 Zohar J, Kaplan Z, Benjamin J. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. J Clin Psychiat. 1994; 55 86-88
- 9 Coleman E, Cesnik J, Moore A M, Dwyer S M. An exploratory study of the role of psychotropic medications in treatment of sexual offenders. J Offender Rehabil. 1992; 18 75-88
- 10 Kafka M P. Sertralin pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial. Ann Clin Psychiat. 1994; 6 189-195
- 11 Kafka M P, Prentky R A. Fluoxetine-treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiat. 1992; 53 351-358
- 12 Bradford J MW. The treatment of sexual deviation using a pharmacological approach. J Sex Res. 2000; 37 248-257
- 13 Bradford J MW, Greenberg D M. Pharmacological treatment of deviant sexual behaviour. Ann Rev Sex Res. 1996; 7 283-306
- 14 Gijs I, Gooren L. Hormonal and psychopharmacological interventions in the treatment of paraphilias: An update. J Sex Res. 1996; 33 273-290
- 15 Greenberg D M, Bradford J MW. Treatment of the paraphilia disorders: A review of the role of selective serotonin reuptake inhibitors. Sexual Abuse. 1997; 9 349-361
- 16 Greenberg D M, Bradford J MW, Curry S, O'Rourke A B. A comparison of treatment of paraphilias with three serotonin reuptake inhibitors. A retrospective study. Bull Am Acad Psychiat & Law. 1996; 24 525-532
- 17 Rösler A, Witztum E. Pharmacotherapy of the paraphilias in the next millenium. Behav Sci Law. 2000; 18 43-56
- 18 Meston C M, Frohlich P F. The neurobiology of sexual function. Arch Gen Psychiat. 2000; 57 1012-1030
- 19 Waldinger M D, Berendsen H H, Blok B F, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation. The involvement of the serotonergic system. Behav Brain Res. 1998; 92 111-118
- 20 Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharm. 1995; 15 341-346
- 21 Coleman E, Gratzer T, Nesvacil L, Raymond N C. Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: A retrospective study. J Clin Psychiat. 2000; 61 282-284
- 22 Kafka M P, Hennen J. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: a case series. J Clin Psychiat. 2000; 61 664-670
- 23 Coccaro E F, Kavoussi R J. Fluoxetine and impulsive agressive behavior in personality-disordered subjects. Arch Gen Psychiat. 1997; 54 1081-1088
- 24 Virkkunen M, Dejong J, Bartko J, Linnoila M. Relationship of psychobiological variables to recidivism in violent offenders and impulsive fire setters: a follow-up study. Arch Gen Psychiat. 1989; 46 600-603
- 25 Virkkunen M, Rawlings R, Tokola R, Poland R E, Guidotti A, Nemeroff C, Bissette G, Kalogeras K, Karonen S L, Linnoila M. CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiat. 1994; 51 20-27
- 26 Olivier B. Serotonergic mechanisms in aggression. Novartis Found Symp. 2005; 268 171-183
- 27 Berner W, Hill A, Briken P, Kraus C. Störungen der Sexualpräferenz - Paraphilien. In: Kockott G, Fahrner E-M (Hrsg.). Sexualstörungen. Stuttgart, New York: Thieme Verlag 2004: 107-152
- 28 Stein D J, Hollander E, Anthony D T, Schneider F R, Fallon B A, Leibowitz M R, Klein D F. Serotonergic medications for sexual obsessions, sexual addiction and paraphilias. J Clin Psychiat. 1992; 53 267-271
- 29 Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. 5. Auflage. Heidelberg: Springer-Verlag 2005
Dr. med. Christian Kraus
Universitätskrankenhaus Hamburg-Eppendorf Klinik für Psychiatrie und Psychotherapie, Station 1
Martinistr. 52
20246 Hamburg
eMail: kraus@uke.uni-hamburg.de